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Abstract
The Ca2/calmodulin-dependent phosphatase calcineurin plays a crucial role in gene expression in different cell types such as
T-lymphocytes, cardiac myocytes, and smooth muscle cells. A possible role for calcineurin in gene expression was recently found in
neurons, where calcineurin regulates the expression of several genes involved in Ca2 homeostasis. To detect additional genes regulated
in a calcineurin-dependent way in neurons we analysed gene expression profiles of cerebellar granule cells cultured in depolarising
conditions in the presence or absence of the calcineurin inhibitory agents FK506 and CsA. Using oligonucleotide arrays we identified 34
genes that are differentially expressed between the samples and confirmed the calcineurin-dependent regulation of some of these genes by
RT-PCR. Therefore, our results, which are likely not to be comprehensive, suggest that calcineurin plays a fundamental role in neuronal
gene expression by either activating or repressing the expression of genes such as receptors, transcription factors, and signalling molecules.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Ca2-signalling plays a central role in neuronal functions
and mediates important events such as neurotransmitter
release, activity-dependent survival, and long-term potenti-
ation (Berridge et al., 2000). Alongside the short-term
events associated with Ca2 rises in neurons, e.g., modula-
tion of the activity of Ca2-dependent enzymes, one of the
important consequences arising from increases in cytosolic
Ca2 levels is change in gene expression. This can occur via
at least two mechanisms (Mellstrom and Naranjo, 2001b):
(1) Ca2 can activate enzymes, such as kinases and phos-
phatases, and these in turn can modulate the activity of
transcription factors; and (2) Ca2 can directly bind to
transcriptional regulators and change their affinity for DNA.
For example, in neurons the cAMP-response element bind-
ing protein (CREB) activity can be regulated by Ca2/
calmodulin kinase II and IV (West et al., 2001), while the
downstream regulatory element DREAM loses affinity for
DNA when Ca2-bound (Mellstrom and Naranjo, 2001a).
This in turn allows its repressor effect to be relieved on the
target gene.
In T lymphocytes, rises in Ca2 activate the Ca2/cal-
modulin phosphatase calcineurin and this leads to subse-
quent dephosphorylation of the transcription factor NFAT
(nuclear factor of activated T cells) in the cytoplasm (Rao et
al., 1997). In turn, the nuclear import sequence on the
NFAT protein is exposed and the transcription factor can
reach the target DNA sequence. This pathway is the site of
action of the immunosuppressants FK506 and cyclosporin
A (CsA), which, by inhibiting calcineurin, block the gene
expression-dependent activation of lymphocytes (Clipstone
and Crabtree, 1992). Furthermore, other cellular systems,
such as cardiac and smooth muscle myocytes, have been
shown to utilise this pathway in development (Graef et al.,
2001a, 2001b) and hypertrophy (Molkentin et al., 1998).
Although calcineurin is abundant in neurons, accounting
for more than 1% of the total protein (Klee et al., 1998), its
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role in gene expression has not been investigated until
recently, when the expression of certain isoforms of the
inositol trisphosphate receptor (IP3R), the plasma mem-
brane Ca2-ATPases (PMCA), and the Na/Ca2 ex-
changer (NCX) in cultured neurons (Genazzani et al., 1999;
Graef et al., 1999; Guerini et al., 2000; Li et al., 2000) have
been shown to be regulated by this phosphatase. IP3R1 has
been shown to undergo upregulation upon calcineurin acti-
vation while PMCA4 and NCX2 undergo downregulation.
Furthermore, the regulation of these genes differs in their
time course, cycloheximide sensitivity, and sole require-
ment for calcineurin activation (Carafoli et al., 1999).
All the genes that have been found so far to be regulated
by calcineurin in neurons appear to be involved in Ca2
homeostasis, thereby providing some kind of activity-de-
pendent reorganisation of Ca2-signalling at the transcrip-
tional level. In the present paper we have investigated
whether genes involved in other functions might be con-
trolled by calcineurin as well. To answer this question, we
used cerebellar granule cells, where it is well-recognised
that activity-dependent survival is dependent on Ca2 influx
(Gallo et al., 1987; Franklin and Johnson, 1992), and have
screened rat oligonucleotide arrays with RNA from cultured
cells grown for 48 h in the presence or absence of the
specific calcineurin antagonists FK506 or cyclosporin A. Of
the approximately 8800 genes and ESTs present on the
arrays, at least 34 were differentially expressed in our cul-
tures. Our data therefore strongly suggest that calcineurin
plays a central role in Ca2- and activity-dependent gene
expression in neurons.
Results and discussion
To investigate target genes for calcineurin-dependent
pathways in cerebellar granule cells, we treated cells with
25 mM KCl (K25) in the presence or absence of 100 nM
FK506 or 1 M cyclosporin A for 48 h. This concentration
of KCl induces a well-documented and long-lasting increase
in resting Ca2 concentrations in cerebellar granule cells
(Franklin and Johnson, 1992; Guerini et al., 1999). To
increase the sensitivity of our assay and reduce false posi-
tives we performed two separate experiments: in the first,
RNA extracted from cells grown in depolarising conditions
(K25) in the presence or absence of FK506 was compared.
In the second, cells were grown under depolarising condi-
tions in the absence or presence of either FK506 or cyclo-
sporin A. Two separate cell cultures were grown for each
treatment and the RNA was pooled. To confirm the reliabil-
ity of our experiments, aliquots of RNA were examined by
gel electrophoresis or were used to perform RT-PCR on two
genes known to be regulated by calcineurin in this model. In
accord with previous reports (Genazzani et al., 1999;
Guerini et al., 2000), IP3R1 RNA was downregulated by
FK506 or CsA treatment, while the NCX2 gene was up-
regulated (data not shown). Once the quality of the RNA
was confirmed, it was used to produce biotin-labelled
cRNA, which was fragmented and hybridised to rat Af-
fymetrix oligonucleotide arrays. Results were computer-
analysed with the algorithm provided in Microarray Suite 5.
To increase the stringency of our results, we pooled
together all the results and excluded all genes that were
called absent in all samples, which left us with 4941 genes
of the 8800 genes represented on the chip. We then com-
pared each FK506 or CsA sample to its respective control
(K25) and selected the genes that were consistently changed
in all samples. Thus, we obtained 94 hits that corresponded
to 86 genes, since some of the genes are replicated on the
microarray. To produce a more reliable list, we then ex-
cluded genes whose hybridisation intensity was below 40
units and set an average threshold change of 1 as a limiting
factor. This left us with 15 genes that are downregulated by
calcineurin inhibition (Table 1) and 19 that were upregu-
lated by FK506 and CsA treatment (Table 2).
To substantiate the results obtained with the oligonucle-
otide array, we randomly chose genes and analysed their
expression by RT-PCR on different RNA samples. Neurons
were cultured in either the presence or absence of depola-
rising concentrations of potassium to strengthen the claim
that calcineurin is activated under depolarising conditions.
Furthermore, FK506 and CsA were used to confirm the
results of the array. The tyrosine kinase receptor Sky, the
neurotrophic factor BDNF (brain-derived neurotrophic fac-
tor), and the neuropeptide transmitter somatostatin (SRIF)
were expressed at higher levels in chronically depolarised
(K25) cells, while cells that were not stimulated (K5) or
were stimulated in the presence of calcineurin inhibitors
displayed no expression or lower levels of expression, re-
spectively (Fig. 1). Similar behaviours were observed with
Lot-1 and the cAMP phosphodiesterase Pde4 genes (Lori,
Table 1
Genes downregulated by inhibition of calcineurin
Fold
change
Accession
No.
Gene
symbol
Gene name PCR
3.2 M25890 Sst, Srif Somatostatin 
2.9 J05510 IP3R1 P3 receptor 
2.7 J04563 Pde4 cAMP phosphodiesterase
2.1 M25350 Pde4 cAMP phosphodiesterase 
1.5 AA799729 Pde4 cAMP phosphodiesterase
2.5 M58364 Gch GTP cyclohydrolase
2.1 AA800908 Unknown
2.1 U72620 Lot1 Lost on transformation 1 
1.9 AA900750 Lot1 Lost on transformation 1
1.7 M59980 Kcnd2 Voltage-gated potassium channel
1.7 AA875084 Unknown
1.3 X86003 Nor-2 Neuron-derived orphan receptor
1.3 AI230211 Kcnd3 Voltage-gated potassium channel
1.3 X66845 Dncic1 Dynein
1.2 X06769 c-fos c-fos 
1.0 X06769 c-fos c-fos
1.2 AI030286 Bdnf Brain-derived neurotrophic factor 
1.1 M93669 Scg2 Secretogranin
1.0 D37880 Tyro3 Receptor tyrosine kinase (Sky) 
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Kramer, and Genazzani, unpublished). The transcription
factor Roaz, the axonal glycoprotein TAG-1, and the can-
nabinoid receptor 1 displayed the opposite pattern, with
RNA being higher in nonstimulated cells and in cells treated
with calcineurin inhibitors (Fig. 1). A similar expression
pattern was observed with somatostatin receptor 2 (sst2), the
GABAB receptor subunit 2 (Gb2), tescalcin, and neurotro-
phic factor receptor TrkB (Kramer, Sanna, Chowdhury, and
Genazzani, unpublished). We therefore assume that Tables
1 and 2 are a true representation of genes that are regulated
by calcineurin in cerebellar granule cells during develop-
ment. The IP3 receptor, the first protein to be described as
regulated by calcineurin in neurons (Genazzani et al., 1999;
Graef et al., 1999), is prominently represented in Table 1.
Nonetheless, other proteins that have been subsequently
shown to be regulated in this fashion, i.e., PMCA4 and
NCX2, are absent (Carafoli et al., 1999). Reexamination of
the data showed that the intensities yielded by these two
genes were low and the genes excluded. This might not be
surprising, due to the low levels of messenger and protein
present at this stage of the culture (Carafoli et al., 1999).
Nonetheless, from these omissions we can conclude that our
list is not exhaustive and that other genes, including those
present at lower levels, are also controlled by calcineurin.
This is further supported by the fact that NGFI-B, a gene
excluded from the final list since its fold change (0.6) was
lower than the set threshold (1.0), was significantly changed
in RT-PCR experiments (not shown).
Calcineurin has been shown to interfere with the activity
of numerous plasma membrane ion channels via binding to
FK binding proteins (Snyder et al., 1998), but this is un-
likely to explain the effects described here. It has been
previously shown that proteins that rely on Ca2 influx, but
that are not controlled by calcineurin, are unaffected by
FK506 or cyclosporin A treatment (Guerini et al., 1999,
2000; Carafoli et al., 1999; Li et al., 2000). Therefore, the
ion channels responsible for Ca2-dependent gene expres-
sion are functional, independent of calcineurin inhibition,
and the regulation we report here is downstream of channel
activation.
Although it is possible that calcineurin controls RNA
levels by regulating mRNA stability (Luo et al., 1999), it is
more likely that calcineurin is involved in controlling the
transcriptional machinery. Which transcription factors
might be regulated in our model to initiate these events? It
is well-established that the transactivating activity of the
transcription factor MEF2 is controlled by calcineurin (Ol-
son and Williams, 2000; Blaeser et al., 2000). RT-PCR with
isoform-specific primers showed that MEF2A, MEF2C, and
MEF2D (myocyte enhancer factor) are present in cerebellar
granule cells at 3 DIV (data not shown), validating the
hypothesis that this factor might be a possible regulator in
our model. This result is in accord with the notion that
MEF2 is responsible for calcium-dependent survival in cer-
ebellar granule cells (Mao and Wiedmann, 1999). One of
the known promoter targets for MEF2 appears to be
NGFI-B (also known as Nur77 or Nr4a1; Blaeser et al.,
2000) and it is suggestive that this gene is regulated in a
calcineurin-dependent manner in our model. Interestingly,
NGFI-B was also the only gene identified in a microarray
screening of seizure-induced gene expression in the CA1
Fig. 1. RT-PCR analysis of calcineurin-regulated genes. mRNA levels
were analysed by RT-PCR using gene-specific primers. Cells were grown
for 48 h in the absence (K5) or presence (K25) of 25 mM KCl. Depolarised
cells were additionally treated with the calcineurin inhibitors FK506 (FK;
100 nM) or cyclosporin A (CsA; 1 M). SRIF, somatostatin; BDNF,
brain-derived neurotrophic factor; TAG-1, transient axonal glycoprotein 1;
Cnr1, cannabinoid receptor 1. All RNA samples were normalised against
the housekeeping genes G3PDH or actin.
Table 2
Genes upregulated by inhibition of calcineurin
Fold
change
Accession
No.
Gene
symbol
Gene name PCR
3.9 M93273 Sst2 Somatostatin receptor 
3.5 AI145494 Syn2 Synapsin
3.0 X62840 Kcnc1 Voltage-dependent
potassium channel
2.9 X55812 Cnr1/Skr6 Cannabinoid receptor 
1.3 U92564 Roaz Olf-1/EBF-associated zinc
finger protein

2.7 AA892511 Tescalcin 
2.7 U35099 Cplx2 Complexin
2.0 X12589 Kcna1 Voltage-gated potassium
channel
1.7 M26161 Kcna1 Voltage-gated potassium
channel
1.7 X04139 Prkcb1 Protein kinase C
1.6 K03486 Prkcb1 Protein kinase C
1.4 U90261 HRVF-1 Hypertension-regulated
vascular factor 1
1.4 AF013144 Cpg21 MAP kinase phosphatase
1.3 M24852 Pcp4 Neuron-specific protein
PEP-19
1.2 AB020504 Pmf31 PMF32 protein
1.2 U16655 Plcd4 Phospholipase C
1.1 M31725 Tax, TAG-1 Transient axonal
glycoprotein 1

1.0 AF058795 Gpr51 Gb2 GABA-B R2 receptor 
1.0 AA866439 Unknown
1.0 AA900505 Arhb RhoB
1.0 M55291 Ntrk2 TrkB 
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region of the hippocampus (French et al., 2001). This opens
the possibility that the Ca2 entry/calcineurin/MEF2 path-
way is involved in neuropathological conditions as well as
in development, paralleling the observation in the heart
(Molkentin et al., 1998; Graef et al., 2001b).
Alongside MEF2, the most commonly cited transcription
factor activated by calcineurin is NFAT (Rao et al., 1997).
It has been recently shown that NFAT might be responsible
for IP3 receptor regulation in hippocampal neurons (Graef et
al., 1999). In our model, RT-PCR revealed that all four
isoforms of NFAT are detectable at 3 DIV and immuno-
blotting revealed that NFATc2, NFATc3, and NFATc4 are
present at the protein level (not shown).
Last, it has been reported that the phosphorylation of
CREB can be regulated indirectly by calcineurin (Bito et al.,
1996). Somatostatin, one of the genes identified in our
screening, has been reported to be under the control of
CREB in numerous cell systems (Montminy and Bilez-
ikjian, 1987). Nonetheless, depolarisation, in contrast to
forskolin treatment, was unable to induce any visible phos-
phorylation of CREB in cerebellar granule cells (data not
shown). This result is paralleled by previous unsuccessful
attempts at inducing CREB phosphorylation by 25 mM KCl
in cerebellar granule cells (Guerini et al., 2000).
Taken together, these data suggest that more than one
Ca2/calcineurin-dependent pathway is potentially active in
cerebellar granule cells grown under depolarising condi-
tions. Similarly, it is possible that some of the identified
genes are regulated by other calcineurin-dependent path-
ways, such as NFB or Elk-1 (Sugimoto et al., 1997; Pons
and Torres-Aleman, 2000). Alongside these transactivating
factors, it is likely that calcineurin also regulates transcrip-
tional suppressors, since more than half of the genes we
identified as differentially expressed were present only
when calcineurin activity was inhibited.
It is likely that not all the genes identified are controlled
by calcineurin directly. Since the time point which was
chosen for this investigation was relatively late (48 h),
calcineurin might regulate the expression of genes which
will in turn then trigger a wider secondary transcriptional
rearrangement. This claim is substantiated by the facts that
several transcription factors (e.g., NGFI-B, c-fos, Roaz, and
Lot1) appear to be under the control of calcineurin and that
it has been reported that the downregulation of PMCA4CII
is dependent on de novo protein synthesis (Guerini et al.,
2000).
It is interesting to note that TAG-1, an axonal glycopro-
tein that has been used as a late neuronal marker to deter-
mine the developmental stage of cerebellar granule cells
(Kuhar et al., 1993), is present at higher levels when cal-
cineurin is blocked. In vivo, migrating immature cerebellar
granule cells express TAG-1 during their migration through
the molecular and Purkinje cell layer, with decreased ex-
pression seen for cells arrived in the internal granule cell
layer. From this, we can infer that in vivo calcineurin
activation occurs once cells have reached their final desti-
nation, the internal granule layer. This would be highly
likely, since the depolarising conditions used in culture are
thought to mimic synaptic connections made between mi-
grated granule neurons and mossy fibers (Gallo et al., 1987).
A further indication of the potential role of calcineurin in
cerebellar granule cell physiology can be drawn from the
changed expression of somatostatin and somatostatin recep-
tors (Yacubova and Komuro, 2002), as well as BDNF and
TrkB receptors (Borghesani et al., 2002). For example, it
has been shown that somatostatin, released from glia, is
involved in the migration pattern of these cells (Yacubova
and Komuro, 2002). Therefore, upon connecting to mossy
fibers and subsequent glutamate signalling, the granule
cells, via calcineurin activation, could downregulate the
somatostatin receptor, preventing the cell from responding
to further somatostatin and therefore signalling arrival at the
final destination in the cerebellum. The simultaneous up-
regulation of somatostatin itself might play a role in com-
munication with further incoming neurons. It would there-
fore appear that calcineurin acts as a cellular switch that
rearranges gene expression in neurons changing from mi-
grating to mature.
It is interesting to note that a similar screening was
recently conducted in T cells (Cristillo and Bierer, 2002).
Although the conclusion by Cristillo and Bierer (2002) was
similar to ours, i.e., calcineurin affects the expression of
numerous genes at the transcriptional level, the genes iden-
tified as differentially expressed were different from those
found in our neuronal model. This suggests that, alongside
calcineurin activation, other tissue-specific factors, not nec-
essarily Ca2-dependent, determine the genes affected by
calcineurin activation or inhibition.
Experimental methods
Cell culture
Cerebellar granule cells were dissociated from the cere-
bella of 7-day-old Wistar rats as described (Gallo et al.,
1987) and plated in DMEM Hepes modification (Invitro-
gen) 10% fetal calf serum (Sigma), 100 g/ml gentamicin,
100 g/ml pyruvate, on poly-L-lysine-treated plates at a
density of approximately 3  105 cells per cm2. After 24 h,
10 M cytosine arabinofuranoside was added to the culture.
All pharmacological treatments were done at this time in the
culture medium.
RNA extraction and RT-PCR
Total RNA was prepared from granule cells by using
Trizol reagent according to the manufacturer’s instructions
(Invitrogen). Total RNA was either used to prepare labelled
cRNA (see below) or was reverse-transcribed by using the
Omniscript RT kit (Qiagen) and a poly (dT) primer (Am-
ersham) according to the manufacturer’s protocol.
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The following nucleotides (written as 5 to 3) were used
for PCR (Sigma Genosys): SRIFF: AGACTCCGTCAGTTT-
CT; R, GAAGAAGTTCTTGCAGCC; BDNFF: CCATGAA-
AGAAGCAAAGTC; R, GAAGTTGGTCTCGTTCATGGC;
SkyF: TGGATGACCCTGACATACAC; R, TAAGGCTGT-
AGTTGGTGGC; RoazF: ACTCCCTCACTGGTTTCCGCT-
GTG; R, CGAAGGTCATCTGGCACTTGATGC; TAG-1F:
AAGTACACGCTGCAAGCTCGTAC; R, GATTCATTTC-
GGAGAGGAACCAC; Cnr1F: ATCCTAGATGGCCTT-
GCAGAC; R, GTGTGGATGATGATGCTCTTC; MEF2F (all
isoforms): TGATGAAGAAGGCTTATGARC; MEF2AR:
CCTCTTCCTCCGAAAGTGG; MEF2BR: CTTGCACA-
GACTGCGG; MEF2CR: CGCCTGTGTTACCTGCAC;
MEF2DR: GGAGTGACCAGAGAGCTAC. The NFAT
primers are described in Stevenson et al. (2001).
Affymetrix oligonucleotide array
To analyse the quality of total RNA, RT-PCR was per-
formed (as described above) for selected genes prior to
sample preparation for oligonucleotide arrays.
Total RNA was reverse-transcribed with the Superscript
Choice system (Invitrogen) using a T7(dT)24 primer, thus
incorporating a T7 RNA polymerase promoter. Double-
stranded cDNA was recovered and used to synthesise bi-
otin-labelled cRNA using the BioArray high yield RNA
transcript labelling kit (Enzo, Farmingdale, NY). Labelled
cRNA was fragmented by incubation at 94°C for 35 min in
fragmentation buffer and 15 g of fragmented cRNA was
hybridised for 16 h at 45°C to an RG-U34A array (Af-
fymetrix, Santa Clara, CA). After hybridisation, a fluidics
station was used to wash and stain the arrays with strepta-
vidin–phycoerythrin. Finally, probe arrays were scanned
and analysed using Affymetrix’s Microarray Suite 5.0 and
sorted by fold change.
Western blotting
Cytosolic proteins were extracted from cells 24 h after
treatment. Granule cells were washed once in phosphate-
buffered saline and collected in a microfuge tube. Cells
were then lysed in low-salt buffer (1.5 mM NaCl, 10 mM
KCl, 0.5 mM DTT, 0.6% NP-40, 10 mM Hepes, pH 7.9) in
the presence of a protease inhibitor cocktail. Cells were
spun down for 60 s at 13,000 rpm and the cytosolic fraction
was collected. Nuclear proteins were extracted by incubat-
ing the nuclei for 20 min at 4°C with intermittent vortexing
in a high-salt solution (25% v/v glycerol, 1.5 mM MgCl2, 1
mM DTT, 420 mM NaCl, 20 mM Hepes, pH 7.9) in the
presence of a protease inhibitor cocktail. Nuclear mem-
branes were centrifuged for 5 min at 13,000 rpm and the
supernatant was collected. Proteins were separated by using
10% acrylamide gel (SDS–PAGE) and transferred to nitro-
cellulose membranes. Membranes were incubated with iso-
form-specific polyclonal antibodies against NFAT isoforms
(Lyakh et al., 1997) kindly donated by Dr. Nancy Rice
(Frederick, MD).
For CREB Western blots total protein was obtained after
3 h of treatment. Cells were harvested on ice in cold solu-
bilisation buffer [50 mM NaCl, 30 mM sodium pyrophos-
phate, 50 mM NaF, 5 mM ZnCl2, 100 M Na3VO4, 200 nM
okadaic acid, 10 mM p-NPP, 1x protease cocktail (Sigma),
0.2 mM PMSF, 0.5 mM benzamidine, 1 mM DTT, 20 mM
-glycerophosphate, 1% Triton] and centrifuged at 13,000
rpm for 15 min at 4°C. Supernatants were collected and
total protein amounts quantified using the Bradford assay. A
total of 100 g of protein was separated in a 10% SDS–
polyacrylamide gel, transferred onto PVDF membranes, and
incubated with CREB and p-CREB-specific antibodies
(NEB).
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